Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Enright

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Developmental Science|May 4, 2006
Choose and choose again: appearance-reality errors, pragmatics and logical abilityGedeon O Deák, Brian Enright
Reproductive Biology and Endocrinology : RB&E|November 15, 2003
Cloning animals by somatic cell nuclear transfer--biological factorsX Cindy Tian, Chikara Kubota, Brian Enright, et al.
Theriogenology|June 18, 2002
Optimization of in vitro bovine embryo production: effect of duration of maturation, length of gamete co-incubation, sperm concentration and sireFabian Ward, Brian Enright, Dimitrios Rizos, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 9, 2024
Paediatric excipient risk assessment (PERA) tool and application for selecting appropriate excipients for paediatric dosage forms - Part 2Anjali Agrawal, Smita Salunke, Alfred Rumondor, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 19, 2024
Selecting appropriate excipients for paediatric dosage form - Paediatric excipients risk assessment (PERA) framework - Part 1Smita Salunke, Anjali Agrawal, Jennifer Walsh, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|December 14, 2011
Incidence and nature of testicular toxicity findings in pharmaceutical developmentJennifer C Sasaki, Robert E Chapin, David Gregory Hall, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 5, 2026
Multimodal Preclinical Assessment of Glucocorticoid-Induced Disruption of Bone Remodeling in Sprague-Dawley RatsAnik Tuladhar, Caitlyn Carter, Erin Vaughan, et al.
Clinical Pharmacology and Therapeutics|April 7, 2022
Science-Based Approach to Harmonize Contraception Recommendations in Clinical Trials and Pharmaceutical LabelsChristopher J Bowman, Nathalie Becourt-Lhote, Virginie Boulifard, et al.
ALTEX|July 18, 2013
In vitro testicular toxicity models: opportunities for advancement via biomedical engineering techniquesLouise Parks Saldutti, Bruce K Beyer, William Breslin, et al.
Journal of Reproductive Immunology|February 25, 2025
Assessing the impact and risk of immunomodulatory compounds on pregnancyJoanne Kwak-Kim, Curtis C Maier, Caren M Villano, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Developmental Science|May 4, 2006
Choose and choose again: appearance-reality errors, pragmatics and logical abilityGedeon O Deák, Brian Enright
Reproductive Biology and Endocrinology : RB&E|November 15, 2003
Cloning animals by somatic cell nuclear transfer--biological factorsX Cindy Tian, Chikara Kubota, Brian Enright, et al.
Theriogenology|June 18, 2002
Optimization of in vitro bovine embryo production: effect of duration of maturation, length of gamete co-incubation, sperm concentration and sireFabian Ward, Brian Enright, Dimitrios Rizos, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 9, 2024
Paediatric excipient risk assessment (PERA) tool and application for selecting appropriate excipients for paediatric dosage forms - Part 2Anjali Agrawal, Smita Salunke, Alfred Rumondor, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 19, 2024
Selecting appropriate excipients for paediatric dosage form - Paediatric excipients risk assessment (PERA) framework - Part 1Smita Salunke, Anjali Agrawal, Jennifer Walsh, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|December 14, 2011
Incidence and nature of testicular toxicity findings in pharmaceutical developmentJennifer C Sasaki, Robert E Chapin, David Gregory Hall, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 5, 2026
Multimodal Preclinical Assessment of Glucocorticoid-Induced Disruption of Bone Remodeling in Sprague-Dawley RatsAnik Tuladhar, Caitlyn Carter, Erin Vaughan, et al.
Clinical Pharmacology and Therapeutics|April 7, 2022
Science-Based Approach to Harmonize Contraception Recommendations in Clinical Trials and Pharmaceutical LabelsChristopher J Bowman, Nathalie Becourt-Lhote, Virginie Boulifard, et al.
ALTEX|July 18, 2013
In vitro testicular toxicity models: opportunities for advancement via biomedical engineering techniquesLouise Parks Saldutti, Bruce K Beyer, William Breslin, et al.
Journal of Reproductive Immunology|February 25, 2025
Assessing the impact and risk of immunomodulatory compounds on pregnancyJoanne Kwak-Kim, Curtis C Maier, Caren M Villano, et al.
Pageof 2